美国FDA生物制品紫皮书数据库
(U.S. FDA Purple Book: Database of Licensed Biological Products)
商品名 申请号 产品号 BLA类型 非专利名称 剂型 给药途径 规格/剂量 产品形式 批准日期 申请人 市场状态 许可证状态 参考产品非专利名称 参考产品专利名称
Pulmozyme 103532 001 351(a) dornase alfa Solution Inhalation 2.5MG/2.5ML (1MG/ML) Ampule 1993/12/30 Genentech, Inc. Rx Licensed N/A N/A
Trasylol 020304 001 351(a) aprotinin Injection Intravenous 1,000,000KIU/100ML (10,000KIU/ML) Single-Dose Vial 1993/12/29 Bayer HealthCare Pharmaceuticals Inc. Disc Licensed N/A N/A
Trasylol 020304 002 351(a) aprotinin Injection Intravenous 2,000,000KIU/200ML (10,000KIU/ML) Single-Dose Vial 1993/12/29 Bayer HealthCare Pharmaceuticals Inc. Disc Licensed N/A N/A
Nutropin 020168 001 351(a) somatropin For Injection Subcutaneous 5MG Multi-Dose Vial 1993/11/17 Genentech, Inc. Disc Voluntarily Revoked N/A N/A
Nutropin 020168 002 351(a) somatropin For Injection Subcutaneous 10MG Multi-Dose Vial 1993/11/17 Genentech, Inc. Disc Voluntarily Revoked N/A N/A
Betaseron 103471 001 351(a) interferon beta-1b For Injection Subcutaneous 0.3MG Single-Dose Vial 1993/07/23 Bayer HealthCare Pharmaceuticals Inc. Rx Licensed N/A N/A
Bioclate (Armour), Recombinate 103375 001 351(a) Antihemophilic Factor (Recombinant) For Injection Intravenous 1000IU Single-Dose Vial 1992/12/10 Takeda Pharmaceuticals U.S.A., Inc. Rx Licensed N/A
Bioclate (Armour), Recombinate 103375 002 351(a) Antihemophilic Factor (Recombinant) For Injection Intravenous 500IU Single-Dose Vial 1992/12/10 Takeda Pharmaceuticals U.S.A., Inc. Rx Licensed N/A
Bioclate (Armour), Recombinate 103375 003 351(a) Antihemophilic Factor (Recombinant) For Injection Intravenous 250IU Single-Dose Vial 1992/12/10 Takeda Pharmaceuticals U.S.A., Inc. Rx Licensed N/A
Orthoclone OKT3 103463 001 351(a) muromonab-CD3 Injection Intravenous 1MG/ML Ampule 1992/09/14 Centocor Ortho Biotech Products, L.P. Disc Voluntarily Revoked N/A N/A
Proleukin 103293 001 351(a) aldesleukin For Injection Intravenous 22MILLION INTERNATIONAL UNITS (1.3MG) Single-Dose Vial 1992/05/05 Iovance Biotherapeutics Manufacturing LLC Rx Licensed N/A N/A
103317 001 351(a) Positive Skin Test Control-Histamine Injection Percutaneous 1.8MG/ML Vial 1992/02/14 Nielsen Bioscience, Inc Disc Licensed N/A
Thrombate Iii 103196 001 351(a) Antithrombin III (Human) For Injection Intravenous 500IU Single-Dose Vial 1991/12/30 Grifols Therapeutics LLC Rx Licensed N/A
Botox Cosmetic 103000 001 351(a) onabotulinumtoxinA For Injection Intramuscular 50UNITS Single-Dose Vial 1991/12/09 AbbVie Inc. Rx Licensed N/A N/A
Botox Cosmetic 103000 002 351(a) onabotulinumtoxinA For Injection Intramuscular 100UNITS Single-Dose Vial 1991/12/09 AbbVie Inc. Rx Licensed N/A N/A
Botox 103000 003 351(a) onabotulinumtoxinA For Injection Injection, Intramuscular, Intradermal, Intradetrusor 50UNITS Single-Dose Vial 1991/12/09 AbbVie Inc. Disc Licensed N/A N/A
Botox 103000 004 351(a) onabotulinumtoxinA For Injection Injection, Intramuscular, Intradermal, Intradetrusor 100UNITS Single-Dose Vial 1991/12/09 AbbVie Inc. Rx Licensed N/A N/A
Botox 103000 005 351(a) onabotulinumtoxinA For Injection Injection, Intramuscular, Intradermal, Intradetrusor 200UNITS Single-Dose Vial 1991/12/09 AbbVie Inc. Rx Licensed N/A N/A
Pharmalgen 103969 001 351(a) Venoms, Honey Bee Venom For Injection Subcutaneous 100UG/ML Multi-Dose Vial 1991/10/08 ALK - Abello A/S Disc Voluntarily Revoked N/A
Pharmalgen 103969 002 351(a) Venoms, Honey Bee Venom For Injection Intradermal 100UG/ML Multi-Dose Vial 1991/10/08 ALK - Abello A/S Disc Voluntarily Revoked N/A
当前数据更新日期:2026年02月10日,更多信息请点击此处查询美国FDA药品数据库

数据库说明:

©2006-2026 DrugFuture->U.S. FDA Purple Book